BioCryst
Medical AFFAIRS
Navigate the Biocryst Medical Affairs Hub with ease
Throughout this resource hub you will find up-to-date information on developing and approved BioCryst medicines, including clinical trials, congress information, published data, and other research material.
Search for medical information
Find information on BioCryst products.
Find information
on previous and upcoming congresses
Upcoming Congress Events
2025 AMCP Nexus Congress
BioCryst will attend the 2025 AMCP Nexus Congress from Oct 27-30, 2025.
Visit the Congress Website for More Information
Materials From Recent Congresses
Showing 105 Materials
-
Suprachoroidal avoralstat, a plasma kallikrein inhibitor, stops vascular leakage in a well-established rabbit model
ASRS | 2025 | DME -
Burden of Treatment for Pediatric Patients (Aged Less Than 12 Years) With Hereditary Angioedema and Their Caregivers
HAEA National Summit | 2025 | HAE -
Patient Perspectives on the Importance of HAE Treatments
HAEA National Summit | 2025 | HAE -
HAE Attack Rates in Pediatric Patients 2 to <12 Years of Age with Prophylactic Berotralstat: Results from Interim Analysis of APeX-P
HAEA National Summit | 2025 | HAE -
Berotralstat Use Reduced Number of HAE Attacks Requiring Treatment or Professional Care in Pediatric Patients: Interim Results From APeX-P
EAACI | 2025 | HAE
Current clinical trials and research
Learn more about medicines being developed at BioCryst and see the latest studies.
Discover more about our areas of focus
Ready to connect or have a question?
Have questions about any of our medicines that are currently approved or in development, or would you like to request to be connected with an MSL?
Have questions about our company?